Anbio Biotechnology Class A Ordinary Shares Stock Forecast

Sell candidate since Aug 04, 2026 Gain 4.53%

The Anbio Biotechnology Class A Ordinary stock price gained 8.82% on the last trading day (Friday, 7th Aug 2026), rising from $9.75 to $10.61. During the last trading day the stock fluctuated 26.39% from a day low at $9.55 to a day high of $12.07. The price has fallen in 5 of the last 10 days but is still up by 7.17% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 25 thousand more shares were traded than the day before. In total, 50 thousand shares were bought and sold for approximately $532.36 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -62.48% during the next 3 months and, with a 90% probability hold a price between $0.85 and $5.64 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

NNNN Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, July 15, 2026, and so far it has risen 16.34%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Anbio Biotechnology Class A Ordinary has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Anbio Biotechnology Class A Ordinary stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $11.50. On a fall, the stock will find some support from the short-term average at $10.28. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss for Anbio Biotechnology Class A Ordinary stock

Anbio Biotechnology Class A Ordinary finds support from accumulated volume at $10.15 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $2.52 between high and low, or 26.39%. For the last week, the stock has had daily average volatility of 18.33%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NNNN) For The Upcoming Trading Day Of Monday 10th

For the upcoming trading day on Monday, 10th we expect Anbio Biotechnology Class A Ordinary Shares to open at $10.74, and during the day (based on 14 day Average True Range), to move between $9.73 and $11.49, which gives a possible trading interval of +/-$1.76 (+/-18.10%) up or down from last closing price. If Anbio Biotechnology Class A Ordinary Shares takes out the full calculated possible swing range there will be an estimated 18.10% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $10.65 (0.38%) than the support at $10.15 (4.34%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Anbio Biotechnology Class A Ordinary Shares stock A Buy?

Anbio Biotechnology Class A Ordinary holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.626 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 10, 2026 - $10.74 ( 1.26%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk